Macquarie Group Ltd

SEC CIK: 0001418333
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

LGND holding history

Ligand Pharmaceuticals Inc in every 13F filed by Macquarie Group Ltd, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

LGND overview All 13F holders of LGND Full Q2 2026 holdings

Shares (Q4 2025): 0; Sold out in Q4 2025
Value: $0
% of portfolio: 0.0%
Quarters held: 19; Since Q1 2021

Holdings of LGND by Macquarie Group Ltd, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q4 2025	0	$0	0.0%	−751,788−100.0%	Sold out	Holders
Q3 2025	751,788	$133.2M	0.2%	−174,766−18.9%	Reduced	Holders
Q2 2025	926,554	$105.3M	0.1%	+20,327+2.2%	Added	Holders
Q1 2025	906,227	$95.3M	0.1%	+21,847+2.5%	Added	Holders
Q4 2024	884,380	$94.8M	0.1%	−2,895−0.3%	Reduced	Holders
Q3 2024	887,275	$88.8M	0.1%	−79,277−8.2%	Reduced	Holders
Q2 2024	966,552	$81.4M	0.1%	−66,629−6.4%	Reduced	Holders
Q1 2024	1,033,181	$75.5M	0.1%	+45,827+4.6%	Added	Holders
Q4 2023	987,354	$70.5M	0.1%	−4,464−0.5%	Reduced	Holders
Q3 2023	991,818	$59.4M	0.1%	+154,648+18.5%	Added	Holders
Q2 2023	837,170	$60.4M	0.1%	+19,187+2.3%	Added	Holders
Q1 2023	817,983	$60.2M	0.1%	+17,387+2.2%	Added	Holders
Q4 2022	800,596	$53.5M	0.1%	+6,975+0.9%	Added	Holders
Q3 2022	793,621	$68.3M	0.1%	+9,697+1.2%	Added	Holders
Q2 2022	783,924	$69.9M	0.1%	+25,183+3.3%	Added	Holders
Q1 2022	758,741	$85.4M	0.1%	+133,772+21.4%	Added	Holders
Q4 2021	624,969	$96.5M	0.1%	−19,809−3.1%	Reduced	Holders
Q3 2021	644,778	$89.8M	0.1%	+51,080+8.6%	Added	Holders
Q2 2021	593,698	$77.9M	0.1%	+109,340+22.6%	Added	Holders
Q1 2021	484,358	$73.8M	0.1%	–	–	Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.